The Valley Desk

NCT06335173 · Interventional trial

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

Overall registry status Active not recruiting

Phase 2

Conditions Alzheimer Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov